桥shui
2020-05-29
别又象开拓药业一样,见光死呀
@新股之火:
《《《移卡配售结果》》》 1、公开发售获得166532份有效认购,认购倍数641.38倍,触发回拨机制,分配比例调整为50%,乙组申请人数4801人,顶头槌215张,一手中签率10%(申购75手稳获1手),以招股价上限16.64元定价(招股价范围12.64-16.64)。 2、国际配售获得大幅超额认购(12倍),分配比例为50%,超额配售权(绿鞋)生效,基石投资者认购约24% 3、公开发售火热,国配大幅超购,且集中于少数人,真是没想到如此之火爆,但中签率也比较感人,中签的相信还有肉吃。 声明:配售结果分析仅供参考。 $开拓药业-B(09939)$$移卡(09923)$$建业新生活(09983)$
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP,发表看法
APP内打开
发表看法
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":951829038,"tweetId":"951829038","gmtCreate":1590737369924,"gmtModify":1704193566040,"author":{"id":3472946487373313,"authorId":3472946487373313,"authorIdStr":"3472946487373313","name":"桥shui","avatar":"https://static.tigerbbs.com/d2fc3bca536d711ca3fbcc6f5db145db","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":0,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>别又象开拓药业一样,见光死呀</p></body></html>","htmlText":"<html><head></head><body><p>别又象开拓药业一样,见光死呀</p></body></html>","text":"别又象开拓药业一样,见光死呀","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/951829038","repostId":951801237,"repostType":1,"repost":{"magic":2,"id":951801237,"tweetId":"951801237","gmtCreate":1590713156929,"gmtModify":1704193485640,"author":{"id":3482723843284168,"authorId":3482723843284168,"authorIdStr":"3482723843284168","name":"新股之火","avatar":"https://static.tigerbbs.com/a9c6e6e9ea83354d7859213b65930a9e","vip":2,"userType":2,"introduction":"专注于港美股打新和低风险套利","boolIsFan":false,"boolIsHead":false,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":1651,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>《《《移卡配售结果》》》<br>1、公开发售获得166532份有效认购,认购倍数641.38倍,触发回拨机制,分配比例调整为50%,乙组申请人数4801人,顶头槌215张,一手中签率10%(申购75手稳获1手),以招股价上限16.64元定价(招股价范围12.64-16.64)。<br>2、国际配售获得大幅超额认购(12倍),分配比例为50%,超额配售权(绿鞋)生效,基石投资者认购约24%<br>3、公开发售火热,国配大幅超购,且集中于少数人,真是没想到如此之火爆,但中签率也比较感人,中签的相信还有肉吃。<br><br>声明:配售结果分析仅供参考。<br><a target=\"_blank\" href=\"https://laohu8.com/S/09939\">$开拓药业-B(09939)$</a><a target=\"_blank\" href=\"https://laohu8.com/S/09923\">$移卡(09923)$</a><a target=\"_blank\" href=\"https://laohu8.com/S/09983\">$建业新生活(09983)$</a><br></p></body></html>","htmlText":"<html><head></head><body><p>《《《移卡配售结果》》》<br>1、公开发售获得166532份有效认购,认购倍数641.38倍,触发回拨机制,分配比例调整为50%,乙组申请人数4801人,顶头槌215张,一手中签率10%(申购75手稳获1手),以招股价上限16.64元定价(招股价范围12.64-16.64)。<br>2、国际配售获得大幅超额认购(12倍),分配比例为50%,超额配售权(绿鞋)生效,基石投资者认购约24%<br>3、公开发售火热,国配大幅超购,且集中于少数人,真是没想到如此之火爆,但中签率也比较感人,中签的相信还有肉吃。<br><br>声明:配售结果分析仅供参考。<br><a target=\"_blank\" href=\"https://laohu8.com/S/09939\">$开拓药业-B(09939)$</a><a target=\"_blank\" href=\"https://laohu8.com/S/09923\">$移卡(09923)$</a><a target=\"_blank\" href=\"https://laohu8.com/S/09983\">$建业新生活(09983)$</a><br></p></body></html>","text":"《《《移卡配售结果》》》 1、公开发售获得166532份有效认购,认购倍数641.38倍,触发回拨机制,分配比例调整为50%,乙组申请人数4801人,顶头槌215张,一手中签率10%(申购75手稳获1手),以招股价上限16.64元定价(招股价范围12.64-16.64)。 2、国际配售获得大幅超额认购(12倍),分配比例为50%,超额配售权(绿鞋)生效,基石投资者认购约24% 3、公开发售火热,国配大幅超购,且集中于少数人,真是没想到如此之火爆,但中签率也比较感人,中签的相信还有肉吃。 声明:配售结果分析仅供参考。 $开拓药业-B(09939)$$移卡(09923)$$建业新生活(09983)$","highlighted":1,"essential":1,"paper":1,"link":"https://laohu8.com/post/951801237","repostId":0,"isVote":1,"tweetType":1,"commentLimit":10,"symbols":["09983","09939","09923"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":472,"xxTargetLangEnum":"ZH_CN"},"isVote":1,"tweetType":1,"viewCount":582,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":27,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/951829038"}
精彩评论